Translational Biomarkers, Merck and Co., Inc., Rahway, NJ 07065, USA
Biography
Matthew J Marton Translational Biomarkers, Merck and Co., Inc., Rahway, NJ 07065, USA prognosis might be less sensitive to tumor heterogeneity than RNA-based expression signatures, at least based on the performance and sensitivity of current DNA/RNA profiling technologies.
